Ufp Technologies (UFPT) EBT Margin (2010 - 2026)
Ufp Technologies' (UFPT) quarterly EBT Margin came in at 15.19% in Q2 2026, up 89.0% on a YoY basis from 8.04% in Q2 2025, and up 8.41% quarter-over-quarter from 14.01% in Q1 2026.
Powered by 
Analysis
Ufp Technologies (UFPT) EBT Margin (2010 - 2026) Analysis & Trends
Ufp Technologies (UFPT) has reported EBT Margin for 17 consecutive years, with 15.19% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin rose 89.0% year-over-year to 15.19%; the trailing twelve-month figure through Jun 2026 stood at 14.03% (up 6.0% YoY), and the FY2025 full-year result was 13.69%, down 79.0% from the prior year.
- EBT Margin grew to 15.19% in Q2 2026 per UFPT's latest filing, from 14.01% in the prior quarter.
- Across five years, EBT Margin topped out at 26.03% in Q3 2022 and bottomed at 8.54% in Q1 2022.
- Historically, EBT Margin has averaged 14.09% across 5 years, with a median of 13.85% in 2026.
- The sharpest annual moves came in 2022 and 2023: EBT Margin surged 1606 bps in 2022, then plunged 1200 bps in 2023.
- Over 5 years, EBT Margin stood at 10.71% in 2022, then increased by 9 bps to 11.72% in 2023, then rose by 13 bps to 13.26% in 2024, then slipped by 1 bps to 13.12% in 2025, then increased by 16 bps to 15.19% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 15.19%, 14.01%, and 13.12% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 18.32% |
| 10 | Ufp Technologies | 2.15 Bn | 2.14 Bn | 50.92 Mn | 15.19% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.19% |
| Mar 31, 2026 | 14.01% |
| Dec 31, 2025 | 13.12% |
| Sep 30, 2025 | 13.63% |
| Jun 30, 2025 | 14.31% |
| Mar 31, 2025 | 13.69% |
| Dec 31, 2024 | 13.26% |
| Sep 30, 2024 | 14.62% |
| Jun 30, 2024 | 15.77% |
| Mar 31, 2024 | 14.60% |
| Dec 31, 2023 | 11.72% |
| Sep 30, 2023 | 14.03% |
| Jun 30, 2023 | 15.97% |
| Mar 31, 2023 | 12.17% |
| Dec 31, 2022 | 10.71% |
| Sep 30, 2022 | 26.03% |
| Jun 30, 2022 | 12.32% |
| Mar 31, 2022 | 8.54% |
| Dec 31, 2021 | 8.22% |
| Sep 30, 2021 | 9.97% |